Home Cart Sign in  
Chemical Structure| 2457232-14-1 Chemical Structure| 2457232-14-1

Structure of G6PDi-1
CAS No.: 2457232-14-1

Chemical Structure| 2457232-14-1

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

G6PDi-1 is a reversible and noncompetitive G6PDH inhibitor with IC50 value of 0.07µM.

Synonyms: Glucose-6-phosphate Dehydrogenase Inhibitor 1

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of G6PDi-1

CAS No. :2457232-14-1
Formula : C14H12N4OS
M.W : 284.34
SMILES Code : N#CC=1SC=C(C1)NC2=NC=C3C(=O)CCCCC3=N2
Synonyms :
Glucose-6-phosphate Dehydrogenase Inhibitor 1
MDL No. :MFCD32899271
InChI Key :USWCHVCZOGGQQA-UHFFFAOYSA-N
Pubchem ID :145998284

Safety of G6PDi-1

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P280-P301+P312-P302+P352-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
CD8+ T cells 10 μM 2 hours To evaluate the effect of G6PDi-1 on NADPH and NADP+ levels, results showed G6PDi-1 significantly decreased NADPH levels and increased NADP+ levels. Nat Chem Biol. 2020 Jul;16(7):731-739
HCT116 cells 10 μM 2 hours To evaluate the effect of G6PDi-1 on NADPH active hydride labeling, results showed G6PDi-1 significantly reduced NADPH labeling. Nat Chem Biol. 2020 Jul;16(7):731-739
primary rat astrocytes 100 nM G6PDi-1 efficiently inhibited G6PDH activity in astrocyte cultures without affecting cell viability, glucose consumption, lactate production, basal glutathione (GSH) export, or the GSH/GSSG ratio. Neurochem Res. 2023 Oct;48(10):3177-3189
cultured primary astrocytes 10 µM 60 minutes To investigate the effect of the glucose-6-phosphate dehydrogenase inhibitor G6PDi-1 on β-lapachone-mediated WST1 reduction. Results showed that G6PDi-1 prevented around 60% of the glucose-dependent WST1 reduction, indicating that pentose phosphate pathway-generated NADPH is the preferred electron source for NQO1-catalysed reductions in astrocytes. Neurochem Res. 2023 Jul;48(7):2148-2160
HepG2 cells 13 μM 2 hours To evaluate the effect of G6PDi-1 on 6-phosphogluconate levels, results showed G6PDi-1 dose-dependently decreased 6-phosphogluconate levels. Nat Chem Biol. 2020 Jul;16(7):731-739
mouse hippocampal brain slices 2.5 μM 10 minutes To assess the effect of G6PDi−1 on intracellular ROS levels. Results showed that G6PDi−1 increased the basal level of intracellular ROS but had no effect on synaptically induced ROS changes. Int J Mol Sci. 2024 Feb 5;25(3):1934
Macrophages 100 nM 48 hours G6PDi-1 reduced K. pneumoniae-induced macrophage recruitment and inflammatory factor expression. Heliyon. 2024 May 7;10(10):e30829
Neutrophils 100 nM 48 hours G6PDi-1 reduced K. pneumoniae-induced neutrophil recruitment and inflammatory factor expression. Heliyon. 2024 May 7;10(10):e30829

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Zebrafish Tg(mpx:EGFP) and Tg(mpeg:EGFP) transgenic zebrafish Water bath administration 100 nM Once daily for 48 hours G6PDi-1 restored K. pneumoniae-induced disruption of circadian rhythm gene expression in zebrafish by reducing inflammation. Heliyon. 2024 May 7;10(10):e30829

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.52mL

0.70mL

0.35mL

17.58mL

3.52mL

1.76mL

35.17mL

7.03mL

3.52mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1

References

 

Historical Records

Categories